Literature DB >> 19673616

Assessing the contribution of the immune reconstitution inflammatory syndrome to mortality in developing country antiretroviral therapy programs.

Mary-Ann Davies, Graeme Meintjes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19673616      PMCID： PMC2752733          DOI： 10.1086/605501

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  15 in total

Review 1.  Immune restoration disease after antiretroviral therapy.

Authors:  Martyn A French; Patricia Price; Shelley F Stone
Journal:  AIDS       Date:  2004-08-20       Impact factor: 4.177

2.  Cryptococcocal immune reconstitution disease: a major cause of early mortality in a South African antiretroviral programme.

Authors:  Stephen D Lawn; Linda-Gail Bekker; Landon Myer; Catherine Orrell; Robin Wood
Journal:  AIDS       Date:  2005-11-18       Impact factor: 4.177

Review 3.  Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals.

Authors:  Stephen D Lawn; Linda-Gail Bekker; Robert F Miller
Journal:  Lancet Infect Dis       Date:  2005-06       Impact factor: 25.071

4.  Fatal unmasking tuberculosis immune reconstitution disease with bronchiolitis obliterans organizing pneumonia: the role of macrophages.

Authors:  Stephen D Lawn; Helen Wainwright; Catherine Orrell
Journal:  AIDS       Date:  2009-01-02       Impact factor: 4.177

5.  Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma.

Authors:  M Bower; M Nelson; A M Young; C Thirlwell; T Newsom-Davis; S Mandalia; T Dhillon; P Holmes; B G Gazzard; J Stebbing
Journal:  J Clin Oncol       Date:  2005-08-01       Impact factor: 44.544

Review 6.  Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa.

Authors:  Stephen D Lawn; Anthony D Harries; Xavier Anglaret; Landon Myer; Robin Wood
Journal:  AIDS       Date:  2008-10-01       Impact factor: 4.177

7.  Immune reconstitution disease associated with mycobacterial infections.

Authors:  Stephen D Lawn; Marc C Lipman; Philippa J Easterbrook
Journal:  Curr Opin HIV AIDS       Date:  2008-07       Impact factor: 4.283

8.  Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients.

Authors:  Anne Bourgarit; Guislaine Carcelain; Valerie Martinez; Caroline Lascoux; Veronique Delcey; Brigitte Gicquel; Eric Vicaut; Philippe H Lagrange; Daniel Sereni; Brigitte Autran
Journal:  AIDS       Date:  2006-01-09       Impact factor: 4.177

9.  Cause-specific mortality and the contribution of immune reconstitution inflammatory syndrome in the first 3 years after antiretroviral therapy initiation in an urban African cohort.

Authors:  Barbara Castelnuovo; Yukari C Manabe; Agnes Kiragga; Moses Kamya; Philippa Easterbrook; Andrew Kambugu
Journal:  Clin Infect Dis       Date:  2009-09-15       Impact factor: 9.079

10.  Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries.

Authors:  Paula Braitstein; Martin W G Brinkhof; François Dabis; Mauro Schechter; Andrew Boulle; Paolo Miotti; Robin Wood; Christian Laurent; Eduardo Sprinz; Catherine Seyler; David R Bangsberg; Eric Balestre; Jonathan A C Sterne; Margaret May; Matthias Egger
Journal:  Lancet       Date:  2006-03-11       Impact factor: 79.321
View more
  9 in total

1.  [Immune reconstitution syndrome].

Authors:  D Meyer-Olson; D Ernst; M Stoll
Journal:  Z Rheumatol       Date:  2012-04       Impact factor: 1.372

Review 2.  Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis.

Authors:  Monika Müller; Simon Wandel; Robert Colebunders; Suzanna Attia; Hansjakob Furrer; Matthias Egger
Journal:  Lancet Infect Dis       Date:  2010-04       Impact factor: 25.071

3.  Impact of the immune reconstitution inflammatory syndrome (IRIS) on mortality and morbidity in HIV-infected patients in Mexico.

Authors:  Irma Hoyo-Ulloa; Pablo F Belaunzarán-Zamudio; Brenda Crabtree-Ramirez; Arturo Galindo-Fraga; María Eugenia Pérez-Aguinaga; Juan G Sierra-Madero
Journal:  Int J Infect Dis       Date:  2011-04-13       Impact factor: 3.623

4.  Th1-driven immune reconstitution disease in Mycobacterium avium-infected mice.

Authors:  Daniel L Barber; Katrin D Mayer-Barber; Lis R V Antonelli; Mark S Wilson; Sandra White; Patricia Caspar; Sara Hieny; Irini Sereti; Alan Sher
Journal:  Blood       Date:  2010-07-23       Impact factor: 22.113

5.  A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of a Chemokine Receptor 5 (CCR5) Antagonist to Decrease the Occurrence of Immune Reconstitution Inflammatory Syndrome in HIV-Infection: The CADIRIS Study.

Authors:  Juan G Sierra-Madero; Susan Ellenberg; Mohammed S Rassool; Ann Tierney; Pablo F Belaunzarán-Zamudio; Alondra López-Martínez; Alicia Piñeirúa-Menéndez; Luis J Montaner; Livio Azzoni; César Rivera Benítez; Irini Sereti; Jaime Andrade-Villanueva; Juan L Mosqueda-Gómez; Benigno Rodriguez; Ian Sanne; Michael M Lederman
Journal:  Lancet HIV       Date:  2014-11-01       Impact factor: 12.767

6.  Opinion: Paracoccidioidomycosis and HIV Immune Recovery Inflammatory Syndrome.

Authors:  Renata Buccheri; Gil Benard
Journal:  Mycopathologia       Date:  2017-11-20       Impact factor: 2.574

7.  Hospital days attributable to immune reconstitution inflammatory syndrome in persons living with HIV before and after the 2012 DHHS HIV guidelines.

Authors:  Peter Liu; Rebecca Dillingham; Kathleen McManus
Journal:  AIDS Res Ther       Date:  2017-05-02       Impact factor: 2.250

8.  Tuberculosis in antiretroviral treatment programs in lower income countries: availability and use of diagnostics and screening.

Authors:  Lukas Fenner; Marie Ballif; Claire Graber; Venerandah Nhandu; Jean Claude Dusingize; Claudia P Cortes; Gabriela Carriquiry; Kathryn Anastos; Daniela Garone; Eefje Jong; Joachim Charles Gnokoro; Omar Sued; Samuel Ajayi; Lameck Diero; Kara Wools-Kaloustian; Sasisopin Kiertiburanakul; Barbara Castelnuovo; Charlotte Lewden; Nicolas Durier; Timothy R Sterling; Matthias Egger
Journal:  PLoS One       Date:  2013-10-17       Impact factor: 3.240

9.  Follow-Up Visit Patterns in an Antiretroviral Therapy (ART) programme in Zomba, Malawi.

Authors:  Beth Rachlis; Donald C Cole; Monique van Lettow; Michael Escobar; Adamson S Muula; Farah Ahmad; James Orbinski; Adrienne K Chan
Journal:  PLoS One       Date:  2014-07-17       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.